Atlas Trials

Patients With B Cell ALL, Relapsed or Refractory, With no Available Curative Treatment Options

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Patients With B Cell ALL, Relapsed or Refractory, With no Available Curative Treatment Options

RecordFirmDate
Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia (NCT02030847)University of Pennsylvania2014-02-27

Track Patients With B Cell ALL, Relapsed or Refractory, With no Available Curative Treatment Options automatically

Every clearance here is in the API, with alerts when new ones post.